Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Betty Pang

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
FDA, FDA and healthcare, FDA and healthcare matters
Office
Bay Area, San Francisco, Washington, D.C.
Active in the record
2020 to 2026

Deal experience

Deal types
Banking & FinanceCapital Markets & IPODebt Capital MarketsJoint VentureM&APrivate Equity & BuyoutsVenture Capital & Growth
Sectors
Consumer & RetailFinancial ServicesHealthcare & Life SciencesTechnology
Jurisdictions
BelgiumCayman IslandsChinaEuropean UnionFranceGermanyIrelandNasdaqUnited KingdomUnited States

Recent deals

127 announced deals in the record
Latham & Watkins Advises Pelthos Therapeutics in Combination With Castle Creek Biosciences 3 Nov 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 300m healthcare regulatory Bay Area
Latham & Watkins Advises Arcus Biosciences on US$250 Million Public Offering of Common Stock 27 Oct 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 250m regulatory Bay Area
Latham Advises on Kimberly-Clark’s US$4.9 Billion Private Offering of Senior Notes 21 Oct 2026
Debt Capital Markets Financial Services Latham & Watkins LLP USD 4.90bn FDA and healthcare
Latham Represents BlackRock and HPS Investment Partners in New Strategic Joint Venture With Humana to Manage CenterWell Senior Primary Care Clinics 14 Oct 2026
Joint Venture Healthcare & Life Sciences Latham & Watkins LLP healthcare
Latham Advises on TRexBio’s US$116.7 Million Initial Public Offering 12 Oct 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 117m regulatory and healthcare
Latham Advises on Vaxcyte’s Concurrent Public Offerings of Common Stock, Pre-Funded Warrants, and Convertible Senior Notes 8 Oct 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 500m regulatory Bay Area
Latham & Watkins Advises Spectrum Equity on Growth Investment in Symmetric Health Solutions 7 Oct 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP healthcare Bay Area
Latham Advises Arsenal Medical in Acquisition by Terumo Neuro 6 Oct 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP healthcare and life sciences
Latham & Watkins Advises on Kimberly-Clark Corporation’s US$7 Billion Exchange Offers and Consent Solicitations 30 Sept 2026
Debt Capital Markets Latham & Watkins LLP USD 7bn FDA and healthcare
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering 28 Sept 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 446m healthcare matters Bay Area
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Betty Pang is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 127 deals for Betty Pang

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction